News & Events
March 23, 2026
Odin Bioscience and Envol Biomedical combine to offer Biological Matrices and Premier NHP Research-Come see us at SOT 2026
As the global toxicology community gathers in San Diego for the Society of Toxicology (SOT) Annual Meeting, sponsors are once...
January 30, 2026
Lessons from Recent Keystone: What the Next Wave of Obesity Research Means for Drug Development
Obesity therapeutics have quickly become one of the most dynamic and competitive areas in modern drug development. At a recent...
January 25, 2026
Envol Biomedical at Keystone Symposia: Advancing Translational Insight in Obesity and Metabolic Disease Research
As the obesity and metabolic disease landscape continues to evolve at a rapid pace, sponsors are increasingly challenged to translate...
April 11, 2025
What the FDA’s Statement on Animal Testing Really Means: A Call to Action to Continue Improving Efficiency in Drug Development
The “Bombshell” News from the FDA (not really). Let’s Clear the Air… On the heels of the FDA’s recent leadership...
March 13, 2024
Join Us in Welcoming Our Newest Additions to Envol Biomedical!
We are delighted to introduce you to two outstanding professionals who have recently joined our team, enriching our capabilities and...
March 5, 2024
Make Your Plans Now to Meet the Envol Team at SOT 2024 in Salt Lake City, Booth 708-UU
Envol Biomedical: Flexibility, Speed, and Accessibility for Advancing NHP Research Needs The team at Envol would like to invite biopharma...
March 4, 2024
Envol Biomedical is pleased to welcome Mason Nondorf to our team!
Mason brings over 15 years of experience as a lead technician in NHP GLP toxicology and safety pharmacology. He was...
January 10, 2024
Envol Biomedical Welcomes Dr. Diana Gerardi Scorpio DVM, MPH, PhD, DACLAM to its Leadership Team
We are incredibly excited to announce the appointment of Dr. Diana Scorpio as the new Director of Comparative Medicine and...
No event found!